In a highly anticipated readout for the kappa opioid receptor class in major depressive disorder, Neumora’s navacaprant ...

Neumora Therapeutics said on Thursday its experimental drug to treat depression failed to meet the main goal of a late-stage study. The study, first of the three late-stage trials, was testing the ...

A groundbreaking depression treatment co-pioneered by Queensland researchers using a new form of brain stimulation will begin ...

Vagus nerve stimulation therapy improved the symptoms of treatment-resistant depression for nearly 500 participants in a ...

“Untreated maternal depression poses serious risks,” she said. “Decisions about treatment should be made by mothers and their healthcare providers together.” New Avenues for Treatment The ...

In a groundbreaking Interview, Professor Raz Yirmiya discusses his innovative research at the intersection of inflammation ...

Launched this year, Miami-based Hope Therapeutics is a developer of NRX-100, a ketamine drug used to treat suicidal ...

Experts say chronic depression affects a lot of adults here in Oklahoma, and they say that the weather, seasonal depression, ...

The technology is not new. It's been around since ... For many patients, after six weeks their depression resolves. For others, they may need more treatment. Overall, the program has had high ...

If you or a loved one is struggling with anxiety or depression, contact the Substance Abuse and Mental Health Services Administration (SAMHSA) National Helpline at 800-662-4357 for information on ...

A groundbreaking clinical trial has revealed that nerve-stimulating therapy can bring significant improvements to people with ...